About this research
Learn about the ComPARe study objectives, how to use this research, the target audience, the funder, study collaborators, and study team members.
What is the ComPARe study? @(Model.HeadingTag)>
The Canadian Population Attributable Risk of Cancer (ComPARe) study estimates the number and percentage of cancer cases in Canada in 2015 due to more than 20 modifiable lifestyle, environmental and infectious agent risk factors.
The study also estimates how changes to these risk factors through prevention could affect the number of cancer cases in the future (up to 2042).
What are the objectives of the ComPARe study? @(Model.HeadingTag)>
The ComPARe study aimed to:
- estimate the current and future number and percentage of new cancer cases due to modifiable risk factors across Canada
- show how prevention strategies can reduce the number of future cancer cases
- work with partners in the health system to share and use the data
Who can use the ComPARe study findings? @(Model.HeadingTag)>
The ComPARe study results are for anyone interested in cancer prevention. Cancer researchers can use this information to support their work. Healthcare providers can use it to educate their patients. Healthcare decision-makers can use it to determine which programs and services to prioritize. And you can use it to understand what you can do to reduce your cancer risk.
The ComPARe study teams brought together experts across Canada in cancer epidemiology, biostatistics, cancer risk factors and knowledge translation.
Learn more about the teams and how they worked together.
Learn more about the teams and how they worked together.
Who did we collaborate with? @(Model.HeadingTag)>
The ComPARe study was supported by the Knowledge Translation Advisory Committee. The committee included the following key collaborators:
- Colorectal Cancer Canada
- Dietitians of Canada
- National Collaborating Centre for Infectious Diseases
- Former Ontario Ministry of Health and Long-Term Care
- Propel Centre for Population Impact
- Public Health Ontario
What was examined in the ComPARe study? @(Model.HeadingTag)>
The ComPARe study examined more than 20 risk factors related to lifestyle, the environment and infectious agents and more than 30 cancer types associated with these risk factors.
Risk factors were selected based on the scientific evidence of their impact on cancer risk and their potential preventability.
How was the study conducted? @(Model.HeadingTag)>
The number of cancer cases due to a risk factor was estimated using a statistical measure called the population attributable risk (PAR), from which ComPARe derives its name. Learn more in our overview of the ComPARe study methods, or see this BMJ Open article for details about the methods.
How was this study funded? @(Model.HeadingTag)>
The ComPARe study was funded by a CCS-Partner Prevention Research Grant from the Canadian Cancer Society (grant #703106).